Bioindustry Business

Product Information

Takara Bio develops original research reagents, scientific instruments, and contracted research services that utilize new genetic and cell engineering technologies on a consistent basis, supporting biotechnology research and bioindustry around the world in fields that range from basic research to drug discovery and development.

Research Reagents and Scientific Instruments

Research reagents
Product Line-up

Promoting Strategies for Three Brands
Promoting Strategies for Three Brands

Takara Bio provides research reagents and scientific instruments needed for life sciences research at universities and private companies. In 2005, Takara Bio acquired United States-based Clontech Laboratories, Inc. (now Takara Bio USA, Inc.), a company that excels in the field of molecular biology. We then acquired Europe-based Cellectis AB (now Takara Bio Europe AB), owner of technologies to induce differentiation of iPS and other stem cells, as well as products related to stem cells, in 2014. This has given the Takara Bio Group ownership of the TaKaRaR, ClontechR, and CellartisR brands and a wide-ranging lineup of research reagent products. Through subsidiaries in the U.S., Europe, China, South Korea, and India, we are working to strengthen brand power and increase sales globally for our three brands.



Contracted Research and Production Services
(CDMO: Contract Development & Manufacturing Organization)

Center for Gene and Cell Processing
Center for Gene and Cell Processing(Kusatsu, Shiga)

Life Innovation Center (Kawasaki, Kanagawa)
Center for Gene and Cell Processing
LIC Branch
(Kawasaki, Kanagawa)

Our CDMO (Contract Development and Manufacturing Organization) business provides high added-value contracted services as an R&D partner to our customers. We provide a seamless package of support services combining regenerative medicine development support services at the Center for Gene and Cell Processing and genetic testing support services such as genetic analysis for genome sequence and regenerative medicine at the Biomedical Center.

1. Contract Services for Developing Regenerative Medicine Products

With the Center for Gene and Cell Processing as our central facility, Takara Bio conducts contracted services that include manufacturing and developing virus vectors and cells for gene transduction based on Good Gene, Cellular and Tissue-based Products Manufacturing Practices (GCTP) and Good Manufacturing Practices (GMP). Other contracted services include quality and safety testing and the production and storage of cell banks. Leveraging technologies and expertise developed through the clinical development of gene and cell therapies, we provide comprehensive support for the research, development, and industrial application of products in the regenerative medicine and cell therapy fields.

2. Contracted Gene Analysis Services

In addition to genetic testing support services such as human genome sequence analysis, comprehensive cancer gene analysis, and intestinal flora analysis, our Biomedical Center provides advanced genetic engineering research support services utilizing state-of-the-art technologies and equipment used in techniques such as next-generation sequencing and genome editing. We are also focused on bioinformatics (life information science), providing high added-value services such as next-generation data mining to draw out useful information from vast quantities of acquired data.

Business Outline

return to top